The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 8th 2025
The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo.
Janssen and Onyx Collaborate to Study Darzalex for Cancer Treatment
November 17th 2016Janssen has entered a clinical trial collaboration and supply agreement with Onyx to evaluate the efficacy and safety of Darzalex, the first-in-class CD38-directed immunotherapy daratumumab, in combination with a proteasome inhibitor carfilzomib and dexamethasone.
Read More
Considerations in Expanded Buprenorphine Access for Opioid Abuse Disorder
November 17th 2016Buprenorphine is one of the most commonly prescribed medications to treat opioid addiction. In 2014, about 60-65% of Americans using medication-assisted treatment received buprenorphine. On July 6, 2016, the Department of Health and Human Services (HHS) announced that it will raise the limit on the number of patients that can receive the addiction medicine buprenorphine to 275 patients per qualified provider. This article describes potential monetary conflicts in proving buprenorphine, how increased access will affect pharmacists and what they can do to help patients in need of medication supported abstinence and substance abuse counseling.
Read More
Baricitinib Shows Early Response, Improved Patient-Reported Outcomes in Rheumatoid Arthritis
November 16th 2016A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira).
Read More
What to Do When Calcium Supplements Cause Constipation
November 16th 2016In pharmacy school, I was taught to see if there was a cause when I learned of a patient?s adverse reaction, because if I?m treating the problem without removing the cause, the problem will still persist. In this situation, I couldn?t remove the cause. If I were to request that the doctor stop prescribing the calcium supplements, the elderly patient would be at higher risk for osteoporosis. If I can?t remove the cause, what can I do in this type of situation?
Read More
APhA Celebrates 20th Anniversary of Pharmacy-Based Immunization Program
November 16th 2016The American Pharmacists Association (APhA) has released a video commemorating the 20th anniversary of its Pharmacy-based Immunization Certificate Training Program and the important role pharmacists are playing within the “immunization neighborhood,” which involves the collaboration, coordination, and communication among immunization stakeholders.
Read More
Improving Diets in Adolescent Girls with Dairy and Plant-Based Foods
November 15th 2016Adolescent females need a wide variety of nutrients for proper development, especially bone health. Neither plant-based food (even if protein-rich) nor dairy products alone provide the necessary range of nutrients.
Read More
Target Populations for HPV Vaccination
November 15th 2016Human papillomavirus (HPV) causes 30,700 cervical, anal, oropharyngeal, penile, and vaginal/vulvar cancer cases annually. Multiple vaccines are available to combat at least the main oncogenic strains 16 and 18 that cause 90% of cancer cases.
Read More
CDC Foundation's Judith Monroe to Receive Award at NACDS Foundation Dinner
November 15th 2016Judith A. Monroe, M.D., FAAFP, president and CEO of the Centers for Disease Control and Prevention (CDC) Foundation, will accept the 2016 NACDS Foundation Excellence in Patient Care Award at the NACDS Foundation Dinner on December 1, 2016, in New York City.
Read More
The American Cancer Society and the CVS Health Foundation have awarded grants to 20 US colleges and universities as part of their Tobacco-Free Generation Campus Initiative, a $3.6 million multi-year program intended to accelerate and expand the adoption and implementation of 100 percent smoke- and tobacco-free campus policies.
Read More
Antidepressant Use in Pregnancy Linked to Speech/Language Disorders
November 14th 2016A study published in JAMA Psychiatry has concluded that infants born to mothers who use selective serotonin reuptake inhibitors (SSRIs) during pregnancy are at higher risk for speech and language disorders during childhood.
Read More
Pharmacy Week in Review: November 11, 2016
November 11th 2016This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional. This week, we welcome guest anchor Terri Warholak, PhD, RPh, CPHQ, FAPhA, who is an associate professor at The University of Arizona College of Pharmacy.
Watch